VOLUNTARY CONTROL OF CORTICOMUSCULAR COHERENCE THROUGH NEUROFEEDBACK: A PROOF-OF-PRINCIPLE STUDY IN HEALTHY SUBJECTS


VON CARLOWITZ-GHORI K., Bayraktaroglu Z., WATERSTRAAT G., CURIO G., NIKULIN V. V.

NEUROSCIENCE, cilt.290, ss.243-254, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 290
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.neuroscience.2015.01.013
  • Dergi Adı: NEUROSCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.243-254
  • İstanbul Üniversitesi Adresli: Evet

Özet

Corticomuscular coherence (CMC) relates to synchronization between activity in the motor cortex and the muscle activity. The strength of CMC can be affected by motor behavior. In a proof-of-principle study, we examined whether independent of motor output parameters, healthy subjects are able to voluntarily modulate CMC in a neuro-feedback paradigm. Subjects received visual online feedback of their instantaneous CMC strength, which was calculated between an optimized spatial projection of multichannel electroencephalography (EEG) and electromyography (EMG) in an individually defined target frequency range. The neurofeedback training consisted of either increasing or decreasing CMC strength using a self-chosen mental strategy while performing a simple motor task. Evaluation of instantaneous coherence showed that CMC strength was significantly larger when subjects had to increase than when to decrease CMC; this difference between the two task conditions did not depend on motor performance. The exclusion of confounding factors such as motor performance, attention and task complexity in study design provides evidence that subjects were able to voluntarily modify CMC independent of motor output parameters. Additional analysis further strengthened the assumption that the subjects' response was specifically shaped by the neurofeedback. In perspective, we suggest that CMC-based neurofeedback could provide a therapeutic approach in clinical conditions, such as motor stroke, where CMC is altered. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.